Ready to contact us for a consultation about your condition and our medical services? The staff of our International Medical Tourism Division is ready to help.
Please select the appropriate button to get started.
Prof. Eytan Mor is an expert in kidney, liver and pancreas transplantation and hepatobiliary surgery. He served as the director of the largest transplantation division in Israel at Beilinson Hospital and Schneider Children’s Hospital, and was the first in the country to perform liver transplants from a live donor in a child and adult. In the field of kidney transplants, he was the first surgeon in Israel to perform incompatible blood type transplants and cross-transplants. Prof. Mor established a cooperation with European countries on this issue. Recently, he performed a unique kidney and bone marrow transplant to stop treatment with immunosuppressive drugs.
Prof. Mor has published more than 170 scientific articles.
Positions
Director of the Organ Transplant Center, Sheba Mdical Center
Full Professor, Faculty of Medicine, Tel Aviv University
Credentials
Education and Training
MD, Hadassah Medical School, the Hebrew University, Jerusalem
Residency in General Surgery, Kaplan Medical Center, Rehovot
Fellowship in Transplantation, Mount Sinai Hospital, New York
Chemotherapy, often referred to as “chemo,” is a type of treatment for cancer that uses medication or a combination of different medications. Read More >>
CAR T therapy is a revolutionary type of blood cancer treatment that programs a patient’s own altered white blood cells to kill cancer cells. Read More >>
Targeted therapy drugs are officially classified as biological treatment. Targeted therapy can be used alone, but it is more often used in conjunction with other cancer treatments. Read More >>
Radiation therapy, also called radiotherapy or irradiation, is one of the most common approaches to cancer therapy. Over half of all people with cancer will be treated with radiation therapy. Read More >>
This is the excerpt. Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children. It is a type of blood and bone marrow cancer that progresses quickly. Read More >>
CML is a type of cancer that originates in the blood-forming cells of the bone marrow. Typically, CML is a slow growing disease, although this disease can later transform into a fast growing acute leukemia. Read More >>
Ewing Sarcoma is a type of cancer that originates in the bone or soft tissue around the bone. It is most commonly discovered in children and teens. Read More >>
A glioma is a type of brain or spinal cord tumor that begins in glial cells, supportive cells that surround the neurons in your brain, nourishing and insulating them. Read More >>
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults and accounts for approximately one-third of all leukemias. Read More >>
CML is a type of cancer that originates in the blood-forming cells of the bone marrow and leads to the production of too many mature white blood cells. Read More >>
Non-Hodgkin Lymphoma (NHL), also called non-Hodgkin’s lymphoma or lymphoma, is a type of cancer that originates in the lymphocytes, or white blood cells. Read More >>
Myelodysplastic syndromes (MDS) are cancers that originate in the bone marrow and affect the growth of blood cells so the body cannot function properly. Read More >>
Multiple myeloma is a blood cancer (related to lymphoma and leukemia) that originates in the plasma cells, which are essential components of your immune system. Read More >>
MF originates in the bone marrow, where it causes fibrous scar tissue to replace the healthy, soft and spongy tissue that is normally inside your bones. Read More >>
Request a Call Back from a
Medical Case Manager at Sheba
Request a Call Back from a
Medical Case Manager at Sheba
Cookies
We have placed cookies on your device to improve your experience on our website, to analyze our traffic and to make assumptions on what advertising may interest you. If you continue to browse we will assume that you are happy with our cookies. Find out more.
